Science in Sport (SIS) investor relations material

Financial performance highlights

• FY24 revenue reached £62.8m, up 17.5% from FY23, with H2 growth of 1.9% over H1.

• Adjusted EBITDA doubled to £4.2m in FY24, a 105% increase from £2.0m in FY23.

• Net debt reduced significantly to £5.9m from £12.9m, reflecting improved cash generation.

• Gross margins improved to over 45% in FY24, up from 43% in FY23.

• Operational improvements and cost base reductions under new leadership drove profitability.

Strategic and operational updates

• Reset of the operating model and cost savings initiatives are underpinning performance gains.

• Distribution agreements and omnichannel sales are supporting domestic and international growth.

• Focus remains on disciplined pricing, operational change, and marketing execution.

• Management is confident in achieving a 15% EBITDA margin earlier than previously anticipated.

• Continued deleveraging and reinvestment for growth are strategic priorities.

Brand and market positioning

• Operates two leading brands: PhD Nutrition (active lifestyle) and SiS (endurance nutrition).

• Products sold via digital platforms, third-party sites, and extensive retail distribution.

• SiS supplies over 320 professional teams and 150 football clubs globally.

• PhD Nutrition recognized for high quality and innovation, with a broad product range.

• Omnichannel approach enables broad market reach in sports nutrition.